James A. DeVoti

1.4k total citations
44 papers, 1.1k citations indexed

About

James A. DeVoti is a scholar working on Immunology, Epidemiology and Oncology. According to data from OpenAlex, James A. DeVoti has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 15 papers in Epidemiology and 12 papers in Oncology. Recurrent topics in James A. DeVoti's work include Immunotherapy and Immune Responses (15 papers), Cervical Cancer and HPV Research (12 papers) and Chemokine receptors and signaling (5 papers). James A. DeVoti is often cited by papers focused on Immunotherapy and Immune Responses (15 papers), Cervical Cancer and HPV Research (12 papers) and Chemokine receptors and signaling (5 papers). James A. DeVoti collaborates with scholars based in United States, Netherlands and Spain. James A. DeVoti's co-authors include Vincent R. Bonagura, Bettie M. Steinberg, Allan L. Abramson, David Rosenthal, Andrea Vambutas, Lynda Hatam, David Beach, Maureen McLeod, Géraldine Seydoux and Eileen Hilton and has published in prestigious journals such as The EMBO Journal, The Journal of Immunology and PLoS ONE.

In The Last Decade

James A. DeVoti

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James A. DeVoti United States 19 454 396 274 233 157 44 1.1k
Lucia E. Rosas United States 18 481 1.1× 292 0.7× 194 0.7× 150 0.6× 53 0.3× 29 1.1k
Valentina Dell’Oste Italy 22 633 1.4× 690 1.7× 402 1.5× 196 0.8× 23 0.1× 49 1.3k
Dennis M. L. Langenberg Netherlands 8 1.3k 2.9× 448 1.1× 400 1.5× 295 1.3× 91 0.6× 8 1.9k
Yinghua Zhao China 18 374 0.8× 86 0.2× 307 1.1× 153 0.7× 63 0.4× 44 1.1k
М. М. Шмаров Russia 18 287 0.6× 311 0.8× 330 1.2× 97 0.4× 34 0.2× 77 962
Betsy C. Taylor United States 9 1.3k 2.9× 163 0.4× 353 1.3× 73 0.3× 65 0.4× 10 2.0k
Simone A. Nish United States 17 1.7k 3.7× 139 0.4× 328 1.2× 305 1.3× 45 0.3× 22 2.1k
Clifton R. White United States 24 164 0.4× 470 1.2× 264 1.0× 458 2.0× 168 1.1× 69 1.6k
Hiroe Shiratsuchi United States 21 458 1.0× 657 1.7× 264 1.0× 367 1.6× 185 1.2× 44 1.5k
Cathrine Knetter United States 7 1.1k 2.4× 233 0.6× 347 1.3× 69 0.3× 71 0.5× 7 1.3k

Countries citing papers authored by James A. DeVoti

Since Specialization
Citations

This map shows the geographic impact of James A. DeVoti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. DeVoti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. DeVoti more than expected).

Fields of papers citing papers by James A. DeVoti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. DeVoti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. DeVoti. The network helps show where James A. DeVoti may publish in the future.

Co-authorship network of co-authors of James A. DeVoti

This figure shows the co-authorship network connecting the top 25 collaborators of James A. DeVoti. A scholar is included among the top collaborators of James A. DeVoti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. DeVoti. James A. DeVoti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Israr, Mohd, James A. DeVoti, F. Lam, et al.. (2025). Oropharyngeal carcinomas induce circulating monocytes to express a TAM-like pro-tumor expression profile that suppresses T-cell proliferation. Frontiers in Immunology. 16. 1539780–1539780.
2.
Einbond, Linda Saxe, Jing Zhou, Mario R. Castellanos, et al.. (2024). Plant Compounds Inhibit the Growth of W12 Cervical Precancer Cells Containing Episomal or Integrant HPV DNA; Tanshinone IIA Synergizes with Curcumin in Cervical Cancer Cells. Viruses. 17(1). 55–55. 3 indexed citations
3.
Israr, Mohd, Fung Lam, James A. DeVoti, et al.. (2023). PGE 2 expression by HPV6/11‐induced respiratory papillomas blocks NK cell activation in patients with recurrent respiratory papillomatosis. European Journal of Immunology. 53(4). e2250036–e2250036. 1 indexed citations
4.
5.
DeVoti, James A., Mohd Israr, Fung Lam, et al.. (2022). Oropharyngeal tumor cells induce COX-2 expression in peripheral blood monocytes by secretion of IL-1α. Frontiers in Immunology. 13. 1011772–1011772. 3 indexed citations
6.
Israr, Mohd, et al.. (2022). Role of chemokines in HPV-induced cancers. Seminars in Cancer Biology. 87. 170–183. 9 indexed citations
7.
Einbond, Linda Saxe, Jing Zhou, Hsan‐au Wu, et al.. (2020). A novel cancer preventative botanical mixture, TriCurin, inhibits viral transcripts and the growth of W12 cervical cells harbouring extrachromosomal or integrated HPV16 DNA. British Journal of Cancer. 124(5). 901–913. 12 indexed citations
8.
Khan, Sundas, et al.. (2017). Effectiveness of montelukast in overweight and obese atopic asthmatics. Annals of Allergy Asthma & Immunology. 119(2). 189–190. 10 indexed citations
9.
DeVoti, James A., Lynda Hatam, Ali R. Afzal, et al.. (2014). Decreased Langerhans Cell Responses to IL-36γ: Altered Innate Immunity in Patients with Recurrent Respiratory Papillomatosis. Molecular Medicine. 20(1). 372–380. 22 indexed citations
10.
Hatam, Lynda, James A. DeVoti, David Rosenthal, et al.. (2012). Immune Suppression in Premalignant Respiratory Papillomas: Enriched Functional CD4+Foxp3+ Regulatory T Cells and PD-1/PD-L1/L2 Expression. Clinical Cancer Research. 18(7). 1925–1935. 82 indexed citations
11.
Rosenthal, David, James A. DeVoti, Bettie M. Steinberg, Allan L. Abramson, & Vincent R. Bonagura. (2012). TH2-like Chemokine Patterns Correlate with Disease Severity in Patients with Recurrent Respiratory Papillomatosis. Molecular Medicine. 18(9). 1338–1345. 26 indexed citations
12.
13.
Bonagura, Vincent R., Zeying Du, Elham Ashouri, et al.. (2009). Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis. Human Immunology. 71(2). 212–219. 57 indexed citations
14.
15.
Shikowitz, Mark J., Allan L. Abramson, Bettie M. Steinberg, et al.. (2005). Clinical Trial of Photodynamic Therapy With Meso-Tetra (Hydroxyphenyl) Chlorin for Respiratory Papillomatosis. Archives of Otolaryngology - Head and Neck Surgery. 131(2). 99–99. 61 indexed citations
16.
Bonagura, Vincent R., Andrea Vambutas, James A. DeVoti, et al.. (2004). HLA alleles, IFN-γ responses to HPV-11 E6, and disease severity in patients with recurrent respiratory papillomatosis. Human Immunology. 65(8). 773–782. 49 indexed citations
17.
Vambutas, Andrea, Vincent R. Bonagura, Elaine F. Reed, et al.. (2004). Polymorphism of Transporter Associated with Antigen Presentation 1 as a Potential Determinant for Severity of Disease in Recurrent Respiratory Papillomatosis Caused by Human Papillomavirus Types 6 and 11. The Journal of Infectious Diseases. 189(5). 871–879. 19 indexed citations
18.
Vambutas, Andrea, et al.. (2001). Interaction of Human Papillomavirus Type 11 E7 Protein with TAP-1 Results in the Reduction of ATP-Dependent Peptide Transport. Clinical Immunology. 101(1). 94–99. 59 indexed citations
19.
Bonagura, Vincent R., et al.. (1999). Recurrent Respiratory Papillomatosis: Altered CD8+ T-Cell Subsets and TH1/TH2 Cytokine Imbalance. Clinical Immunology. 93(3). 302–311. 63 indexed citations
20.
Hilton, Eileen, et al.. (1999). Seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the northeast United States. The American Journal of Medicine. 106(4). 404–409. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucia E. Rosas Breakdown of academic impact, for papers by Valentina Dell’Oste Breakdown of academic impact, for papers by Dennis M. L. Langenberg Breakdown of academic impact, for papers by Yinghua Zhao Breakdown of academic impact, for papers by М. М. Шмаров Breakdown of academic impact, for papers by Betsy C. Taylor Breakdown of academic impact, for papers by Simone A. Nish Breakdown of academic impact, for papers by Clifton R. White Breakdown of academic impact, for papers by Hiroe Shiratsuchi Breakdown of academic impact, for papers by Cathrine Knetter
Rankless by CCL
2026